Notably, the combined treatment of cerivastatin and crizotinib produced a potent anti‐tumor synergy compared with that of crizotinib (P < 0.05) or cerivastatin alone (P < 0.05) in YAP‐WT xenograft. The gene discussed is YAP1; the disease is neoplasm.